MarginsXMarginsX
Home › Markets › ESMC

Escalon Medical Corp (ESMC)

ESMC is quoted over the counter, not listed on an exchange. Escalon Medical Corp files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 12, 2026
$0.1700
No trades since Nov 12, 2026; later closes repeat the last quote
1-year return
0.0%
Market cap
$1.3M
Nano cap. From the Nov 12, 2026 last trade × 7.4M shares (10-K cover page, Sep 25, 2026)
P/E and P/S
0.3× · 0.1×
On trailing twelve months to June 30, 2026 (10-K)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerESMC, quoted over the counter
SEC CIK0000862668
OTC Markets tierOTCQB (price source, 2026-11-13)
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Business addressWayne, PA
Incorporated inPA

Warning signs

Cash runway
91.4 months
$3.1M cash at June 30, 2026
Share count, 1 year
0.0%
2025-09-26 to 2026-09-25 · 0.0% over 3 years
Going-concern doubt
No
10-K filed October 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-K 2026-10-13
Cash and burn$3.1M cash; operating cash flow -$101K a quarter.Report 2026-06-30
Shares outstanding7,415,329 (2026-09-25); 7,415,329 a year earlier; 7,415,329 three years earlier.Cover page 2026-09-25
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorCBIZ CPAs P.C., Marlton, New Jersey, United States; changed auditors 1 time in 24 months8-K 4.01 2025-04-04
Late filings, 12 months1 NT noticeNT 10-K 2026-09-28
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q4 2026
2026-06-30
$3.9M$1.8M-$251K$3.1MNo debt tags$12.7M10-K 2026-10-13
Q3 2026
2026-03-31
$2.6M$2.4M$281K$3.3MNo debt tags$11.4M10-Q 2026-05-15
Q2 2026
2025-12-31
$3.6M$98K-$517K$337KNo debt tags$12.3M10-Q 2026-02-17
Q1 2026
2025-09-30
$2.7M-$240K$85K$616KNo debt tags$11.9M10-Q 2025-11-14
Q4 2025
2025-06-30
$2.6M-$380K$16K$546KNo debt tags$12.0M10-K 2026-10-13
Q3 2025
2025-03-31
$3.5M$271K$31K$541K$40KNeeds four quarters10-Q 2025-05-14
Q2 2025
2024-12-31
$3.2M$246K$301K$521K$38KNeeds four quarters10-Q 2025-02-14
Q1 2025
2024-09-30
$2.8M-$32K$33K$230K$38KNeeds four quarters10-Q 2025-11-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32009-02-09
Latest annual report10-K2026-10-13
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-01-29
Latest proxyDEF 14A2017-05-18

Source: SEC EDGAR submissions feed, 466 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier